Mad Money Lightning Round OT: Cramer Likes CERN And XIDE, Dislikes MNKD

Jim Cramer said on CNBC's Mad Money Lightning Round OT that he can't recommend MannKind Corporation MNKD, because it has some FDA hurdles ahead. He doesn't want to short it, but MNKD doesn't have a potential like some of the stocks he likes. MannKind (MNKD) dropped 3.27% in today's trading session. Exide Technologies XIDE is a good speculative stock, thinks Cramer. He likes it because its batteries are used by navy. Exide (XIDE) fell 1.99% today. Cerner Corporation CERN was Cramer's second favorite stock in the space, after Allscripts-Misys Healthcare Solutions MDRX. Currently, he likes Cerner Corporation (CERN) more, until we are through with the Misys separation with Allscripts.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: CNBCLong IdeasJim CramerShort IdeasMediaTrading IdeasAuto Parts & EquipmentBiotechnologyConsumer DiscretionaryHealth CareHealth Care TechnologyJim Cramer
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!